Back to Search
MARK BACKLUND, MD
MD
Psychiatry Physician
NPI: 1306883152Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Targeting the eicosanoid pathway in non-small-cell lung cancer.
PMID 19409031·Expert Opin Ther Targets·2009
6-review
Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis.
PMID 19010439·Prostaglandins Other Lipid Mediat·2009
7-preclinical
Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase.
PMID 19246543·Nucleic Acids Res·2009
8-other
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
PMID 18676872·Cancer Res·2008
7-preclinical
Novel strategies for the treatment of lung cancer: modulation of eicosanoids.
PMID 18281650·J Clin Oncol·2008
8-other
Unexpected C-H activation of Ru(II)-dithiomaltol complexes upon oxidation.
PMID 18257546·Inorg Chem·2008
8-other
Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data.
PMID 18445660·Mol Cancer Ther·2008
8-other
Regulation of prostaglandin transporters in colorectal neoplasia.
PMID 19138942·Cancer Prev Res (Phila)·2008
7-preclinical
Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.
PMID 19010907·Cancer Res·2008
7-preclinical
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
PMID 17493263·Genome Biol·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1103 CLEVELAND AVE
MOUNT VERNON, WA 98273 - Phone
- (360) 336-6868
Quick Facts
- NPI
- 1306883152
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile